top of page
Dr Mark Wilkinson

Dr Mark Wilkinson

Co-founder & CSO

Mark completed his undergraduate and masters in Biochemistry at the University of Oxford. He then completed an MSc and PhD at Imperial College London, where he developed a biosynthetic platform for antimalarial drug discovery and a single molecule method for studying protein folding. Before joining Bactobio, he was based at the Drug Discovery Unit at GlaxoSmithKline in Madrid.

​

Mark joined Bactobio in September 2020 and oversees scientific projects from microbial generation through to compound discovery.

​

Outside of the lab, Mark can be found in the kitchen cooking and baking or travelling around the world on his bike.

Get in touch

bottom of page